Lowell E. Sears is listed as a director on 14 SEC Form D filings by 6 issuers between Apr 2009 and Feb 2017. Largest by amount reported sold: IMMUNIC, INC. (New York, United States (as filed: X1) — biotechnology — 2013–2014; $200M reported sold to 62 investors), Intekrin Therapeutics Inc (Los Altos, CA — pharmaceuticals — 2009–2010; $21.4M reported sold to 12 investors), CORTHERA INC (San Mateo, CA — industry reported as "Other" — 2009; $15M reported sold to 4 investors), SiteOne Therapeutics, Inc. (Bozeman, MT — pharmaceuticals — 2015–2017; $14.9M reported sold to 19 investors), Cellerant Therapeutics Inc (San Carlos, CA — biotechnology — 2012–2016; $6.55M reported sold to 10 investors) and 1 more (all listed below).
What this means A repeat sponsor — 6 separate companies raised money with this person listed as director, over about 8 years. Across those companies the filings report $258.8M sold in total.
Listed alongside Aron Stern (4 shared filings), Douglas Godshall (4 shared filings), Duane Nash (4 shared filings), Errol R. Halperin (4 shared filings), J. Michael Millis (4 shared filings) and 54 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Lowell. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 14 public filings for Lowell E. Sears and found 8 differences, 2 worth asking the sponsor about: Form D filed 275 days after the first sale; Lowell E. Sears is no longer listed on the Feb 12, 2019 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.